Targeting microglial α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's disease

Y Li, Y Xia, S Yin, F Wan, J Hu, L Kou, Y Sun… - Frontiers in …, 2021 - frontiersin.org
According to emerging studies, the excessive activation of microglia and the subsequent
release of pro-inflammatory cytokines play important roles in the pathogenesis and …

The genetics of Parkinson disease

H Deng, P Wang, J Jankovic - Ageing research reviews, 2018 - Elsevier
About 15% of patients with Parkinson disease (PD) have family history and 5–10% have a
monogenic form of the disease with Mendelian inheritance. To date, at least 23 loci and 19 …

α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis

S Mehra, S Sahay, SK Maji - Biochimica et Biophysica Acta (BBA)-Proteins …, 2019 - Elsevier
Abstract α-Synuclein (α-Syn) has been extensively studied for its structural and biophysical
properties owing to its pathophysiological role in Parkinson's disease (PD). Lewy bodies …

The physiological role of α‐synuclein and its relationship to Parkinson's Disease

D Sulzer, RH Edwards - Journal of neurochemistry, 2019 - Wiley Online Library
The protein α‐synuclein has a central role in the pathogenesis of Parkinson's disease (PD).
In this review, we discuss recent results concerning its primary function, which appears to be …

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

YC Wong, D Krainc - Nature medicine, 2017 - nature.com
Alterations in α-synuclein dosage lead to familial Parkinson's disease (PD), and its
accumulation results in synucleinopathies that include PD, dementia with Lewy bodies …

Cell biology and pathophysiology of α-synuclein

J Burré, M Sharma, TC Südhof - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
α-Synuclein is an abundant neuronal protein that is highly enriched in presynaptic nerve
terminals. Genetics and neuropathology studies link α-synuclein to Parkinson's disease (PD) …

The synucleinopathies: twenty years on

M Goedert, R Jakes… - Journal of Parkinson's …, 2017 - content.iospress.com
In 2017, it is two hundred years since James Parkinson provided the first complete clinical
description of the disease named after him, fifty years since the introduction of high-dose D …

α‐synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities

P Alam, L Bousset, R Melki… - Journal of …, 2019 - Wiley Online Library
This review article provides an overview of the different species that α‐synuclein aggregates
can populate. It also attempts to reconcile conflicting views regarding the cytotoxic roles of …

Reverse engineering Lewy bodies: how far have we come and how far can we go?

MB Fares, S Jagannath, HA Lashuel - Nature Reviews Neuroscience, 2021 - nature.com
Lewy bodies (LBs) are α-synuclein (α-syn)-rich intracellular inclusions that are an important
pathological hallmark of Parkinson disease and several other neurodegenerative diseases …

Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy

R Guerrero-Ferreira, NMI Taylor, AA Arteni, P Kumari… - Elife, 2019 - elifesciences.org
Intracellular inclusions rich in alpha-synuclein are a hallmark of several neuropathological
diseases including Parkinson's disease (PD). Previously, we reported the structure of alpha …